Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 330 participants.
Also called NCT06954155
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 330 participants
- Sponsor
- Registry
-
NCT06954155
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06954155. Randomized; single masking; primary purpose treatment. Start 2025-05-30 (actual); primary completion 2027-02-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND
- Acronym
- TRACE-BEYOND
- Condition
- Stroke
- Intervention (Drug)
- Tenecteplase (0.25mg/kg)
- Intervention (Drug)
- Standard medical treatment
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct06954155- Content hash
1ea6e5d2887cb18d89796b418165233b5138974f71f08692cd8e805ebf7949c5